Development of novel PP2A activators for use in the treatment of acute myeloid leukaemia

- Toop, Hamish D., Dun, Matthew D., Ross, Bryony K., Flanagan, Hayley M., Verrills, Nicole M., Morris, Jonathan C.

MicroRNA-9 regulates steroid-resistant airway hyperresponsiveness by reducing protein phosphatase 2A activity

- Li, Jing Jing, Tay, Hock L., Mattes, Joerg, Foster, Paul S., Yang, Ming, Maltby, Steven, Xiang, Yang, Eyers, Fiona, Hatchwell, Luke, Zhou, Hong, Toop, Hamish D., Morris, Jonathan C., Nair, Parameswaran

Salmeterol attenuates chemotactic responses in rhinovirus-induced exacerbation of allergic airways disease by modulating protein phosphatase 2A

- Hatchwell, Luke, Girkin, Jason, Mattes, Joerg, Dun, Matthew D., Morten, Matthew, Verrills, Nicole, Toop, Hamish D., Morris, Jonathan C., Johnson, Sebastian L., Foster, Paul S., Collison , Adam

Shwachman-Bodian-Diamond syndrome (SBDS) protein is a direct inhibitor of protein phosphatase 2A (PP2A) activity and overexpressed in acute myeloid leukaemia

- Dun, Matthew D., Mannan, Abdul, Germon, Zacary, Faulkner, Sam, Chi, Mengna, Skerrett-Byrne, David, Murray, Heather C., Flanagan, Hayley, Almazi, Juhura G., Hondermarck, Hubert, Nixon, Brett, De Iuliis, Geoff, Rigby, Callum J., Chamberlain, J, Alvaro, F, de Bock, CE, Morris, JC, Enjeti, Anoop K., Verrills, Nicole M., Butler, Stephen, Toop, Hamish D., Beck, Dominik, Connerty, Patrick, Sillar, Jonathan, Kahl, Richard G. S., Duchatel, Ryan J.

TRAIL signals through the ubiquitin ligase MID1 to promote pulmonary fibrosis

- Collison, Adam M., Li, Junyao, de Siqueira, Ana Pereira, Lv, Xuejiao, Toop, Hamish D., Morris, Jonathan C., Starkey, Malcolm R., Hansbro, Philip M., Zhang, Jie, Mattes, Joerg

Tumor necrosis factor-related apoptosis-inducing ligand regulates hallmark features of airways remodeling in allergic airways disease

- Collison, Adam, Li, Junyao, Pereira de Siqueira, Ana, Zhang, Jie, Toop, Hamish D., Morris, Jonathan C., Foster, Paul S., Mattes, Joerg